Research
Hormonal
In healthy adults, belonging to the second quartile of dietary glycemic index (GI) is associated with significantly lower odds of having elevated fasting blood glucose (hyperglycemia) compared to the lowest quartile.
You don't need to aim for the absolute lowest glycemic index foods to maintain healthy blood sugar. A moderate GI (second quartile) was associated with lower odds of high fasting blood glucose in this study. Focus on a balanced diet rather than extreme low-GI restrictions.
ModerateQualifiesMEDIUM confidence
Participants belonging to the second quartile of GI had significantly lower odds of having hyperglycemia (OR: 0.380, 95% CI:0.174–0.833).
Why this rating
Cross-sectional, specific subgroup, but statistically significant after adjustment.
Source
Dietary Glycemic Index and Glycemic Load Are Not Associated with the Metabolic Syndrome in Lebanese Healthy Adults: A Cross-Sectional Study
Cecile Borgi et al. · Nutrients · 2020
DOI 10.3390/nu12051394
cross_sectional · n=283Cited 3×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- In healthy adults, dietary glycemic index (GI) and glycemic load (GL) are not significantly associated with metabolic syndrome after adjusting for confounders such as BMI, physical activity, and macronutrient intake.Good
- In healthy adults, there is no significant association between dietary glycemic load (GL) and metabolic syndrome or its components.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →